Rothman RB, Xu H, Seggel M, Jacobson AE, Rice KC, Brine GA, Carroll FI (April 1991). "RTI-4614-4: an analog of (+)-cis-3-methylfentanyl with a 27,000-fold binding selectivity for mu versus delta opioid binding sites". Life Sciences. 48 (23): PL111–PL116. doi:10.1016/0024-3205(91)90346-D. PMID1646357.
Brine GA, Stark PA, Liu Y, Carroll FI, Singh P, Xu H, Rothman RB (April 1995). "Enantiomers of diastereomeric cis-N-[1-(2-hydroxy-2-phenylethyl)- 3-methyl-4-piperidyl]-N-phenylpropanamides: synthesis, X-ray analysis, and biological activities". Journal of Medicinal Chemistry. 38 (9): 1547–1557. doi:10.1021/jm00009a015. PMID7739013.
Wang ZX, Zhu YC, Jin WQ, Chen XJ, Chen J, Ji RY, Chi ZQ (September 1995). "Stereoisomers of N-[1-hydroxy-(2-phenylethyl)-3-methyl-4-piperidyl]- N-phenylpropanamide: synthesis, stereochemistry, analgesic activity, and opioid receptor binding characteristics". Journal of Medicinal Chemistry. 38 (18): 3652–3659. doi:10.1021/jm00018a026. PMID7658453.
Guo GW, He Y, Jin WQ, Zou Y, Zhu YC, Chi ZQ (June 2000). "Comparison of physical dependence of ohmefentanyl stereoisomers in mice". Life Sciences. 67 (2): 113–120. doi:10.1016/S0024-3205(00)00617-2. PMID10901279.
Liu ZH, He Y, Jin WQ, Chen XJ, Shen QX, Chi ZQ (April 2004). "Effect of chronic treatment of ohmefentanyl stereoisomers on cyclic AMP formation in Sf9 insect cells expressing human mu-opioid receptors". Life Sciences. 74 (24): 3001–3008. doi:10.1016/j.lfs.2003.10.027. PMID15051423.
Brine GA, Carroll FI, Richardson-Leibert TM, Xu H, Rothman RB (August 1997). "Ohmefentanyl and its stereoisomers: Chemistry and pharmacology". Current Medicinal Chemistry. 4 (4): 247–270. doi:10.2174/0929867304666220313115017. ISSN0929-8673.
Mounteney J, Giraudon I, Denissov G, Griffiths P (July 2015). "Fentanyls: Are we missing the signs? Highly potent and on the rise in Europe". The International Journal on Drug Policy. 26 (7): 626–631. doi:10.1016/j.drugpo.2015.04.003. PMID25976511.
dtic.mil
apps.dtic.mil
H. D. Banks, C. P. Ferguson (September 1988). "The Metabolites of Fentanyl and its Derivatives"(PDF). U.S. Army Chemical Research, Development and Engineering Center, Aberdeen Proving Ground, MD. Archived(PDF) from the original on July 14, 2014.
Rothman RB, Xu H, Seggel M, Jacobson AE, Rice KC, Brine GA, Carroll FI (April 1991). "RTI-4614-4: an analog of (+)-cis-3-methylfentanyl with a 27,000-fold binding selectivity for mu versus delta opioid binding sites". Life Sciences. 48 (23): PL111–PL116. doi:10.1016/0024-3205(91)90346-D. PMID1646357.
Brine GA, Stark PA, Liu Y, Carroll FI, Singh P, Xu H, Rothman RB (April 1995). "Enantiomers of diastereomeric cis-N-[1-(2-hydroxy-2-phenylethyl)- 3-methyl-4-piperidyl]-N-phenylpropanamides: synthesis, X-ray analysis, and biological activities". Journal of Medicinal Chemistry. 38 (9): 1547–1557. doi:10.1021/jm00009a015. PMID7739013.
Wang ZX, Zhu YC, Jin WQ, Chen XJ, Chen J, Ji RY, Chi ZQ (September 1995). "Stereoisomers of N-[1-hydroxy-(2-phenylethyl)-3-methyl-4-piperidyl]- N-phenylpropanamide: synthesis, stereochemistry, analgesic activity, and opioid receptor binding characteristics". Journal of Medicinal Chemistry. 38 (18): 3652–3659. doi:10.1021/jm00018a026. PMID7658453.
Jin WQ, Xu H, Zhu YC, Fang SN, Xia XL, Huang ZM, et al. (May 1981). "Studies on synthesis and relationship between analgesic activity and receptor affinity for 3-methyl fentanyl derivatives". Scientia Sinica. 24 (5): 710–720. PMID6264594.
Zhu YC, Wu RQ, Chou DP, Huang ZM (December 1983). "[Studies on potent analgesics. VII. Synthesis and analgesic activity of diastereoisomers of 1-beta-hydroxy-3-methylfentanyl (7302) and related compounds]". Yao Xue Xue Bao = Acta Pharmaceutica Sinica. 18 (12): 900–904. PMID6679170.
Guo GW, He Y, Jin WQ, Zou Y, Zhu YC, Chi ZQ (June 2000). "Comparison of physical dependence of ohmefentanyl stereoisomers in mice". Life Sciences. 67 (2): 113–120. doi:10.1016/S0024-3205(00)00617-2. PMID10901279.
Liu ZH, He Y, Jin WQ, Chen XJ, Shen QX, Chi ZQ (April 2004). "Effect of chronic treatment of ohmefentanyl stereoisomers on cyclic AMP formation in Sf9 insect cells expressing human mu-opioid receptors". Life Sciences. 74 (24): 3001–3008. doi:10.1016/j.lfs.2003.10.027. PMID15051423.
Mounteney J, Giraudon I, Denissov G, Griffiths P (July 2015). "Fentanyls: Are we missing the signs? Highly potent and on the rise in Europe". The International Journal on Drug Policy. 26 (7): 626–631. doi:10.1016/j.drugpo.2015.04.003. PMID25976511.
web.archive.org
H. D. Banks, C. P. Ferguson (September 1988). "The Metabolites of Fentanyl and its Derivatives"(PDF). U.S. Army Chemical Research, Development and Engineering Center, Aberdeen Proving Ground, MD. Archived(PDF) from the original on July 14, 2014.
worldcat.org
search.worldcat.org
Brine GA, Carroll FI, Richardson-Leibert TM, Xu H, Rothman RB (August 1997). "Ohmefentanyl and its stereoisomers: Chemistry and pharmacology". Current Medicinal Chemistry. 4 (4): 247–270. doi:10.2174/0929867304666220313115017. ISSN0929-8673.